Association of Angiotensin Receptor-Neprilysin Inhibitors Use and Better Cardiorenal Outcomes in Patients With Heart Failure and Acute Kidney Disease
In HF patients with AKD, ARNi was associated with reduced all-cause mortality, MAKE, and readmission risks compared to ACEi, particularly with concurrent mineralocorticoids, diuretics, or beta-blockers. Future research is necessary to further investigate the impact of ARNi on outcomes in patients with HF and AKD.
Authors
- Vin‐Cent Wu (ORCID: https://orcid.org/0000-0001-7935-0991)
- Jui‐Yi Chen (ORCID: https://orcid.org/0000-0003-1376-7780)
- Heng-Chih Pan
Institutions
- National Taiwan University (TW)
- Keelung Chang Gung Memorial Hospital (TW)
- National Taiwan University Hospital (TW)
- Chi Mei Medical Center (TW)
- Chia Nan University of Pharmacy and Science (TW)
Publication Details
- Journal
- Cardiovascular Drugs and Therapy
- Published
- 2025-04-23
- DOI
- https://doi.org/10.1007/s10557-025-07698-x
- Citations
- 1
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- National Science Council
- National Taiwan University Hospital
- National Taiwan University
- Chi Mei Medical Center
- National Science and Technology Council